Skip to content

Objective Monitoring for Conscious Sedation during Colonoscopy

Efficacy of Bispectral Monitoring for Propofol and Midazolam induced Sedation During Colonoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000464
Enrollment
120
Registered
2012-06-26
Start date
2011-04-12
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University Seoul Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy adult

Exclusion criteria

Exclusion criteria: Excluded from the study were patients with ASA status III or higher, those who refused sedation during colonoscopy, who were hospitalized, and who were pregnant or lactating, as well as patients with an allergy to eggs, beans or latex, with a previous history of alcohol or sedative overdose and adverse events associated with propofol, with sleep apnea or acute gastrointestinal hemorrhage and with a recent history of central nervous system (CNS) abnormalities (e.g. stroke).

Design outcomes

Primary

MeasureTime frame
safety of sedation : blood pressure, pulse rate, saturation, complication of procedure ;efficacy of sedation : satisfaction of patients, doses of sedative drug

Secondary

MeasureTime frame
satisfaction of endoscopist

Countries

Korea, Republic of

Contacts

Public ContactYeon Hwa Yu

Hanyang University Seoul Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026